Age-specific performance of the revised cardiac risk index for predicting cardiovascular risk in elective noncardiac

Charlotte Andersson1, Mads Wissenberg2, Mads Emil Jørgensen2

  • 1From the Department of Cardiology, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark (C.A., M.W., M.E.J., C.M., G.H.G.); Department of Health Research and Policy, Stanford University, CA (M.A.H.); Department of Cardiothoracic Anesthesia, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark (P.F.J.); The National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark (G.H.G.); The Heart Center, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark (L.K.); and Institute of Health, Science and Technology, Aalborg University, Aalborg, Denmark (C.T.-P.). ca@heart.dk.

Insights

The revised cardiac risk index (RCRI) effectively predicts major adverse cardiovascular events in noncardiac surgery patients across all ages. While sensitivity varies, its high negative predictive value ensures reliable risk assessment for preoperative cardiac evaluation.

Area of Science:

  • Cardiology
  • Anesthesiology
  • Geriatric Medicine

Background:

  • The revised cardiac risk index (RCRI) is crucial for preoperative cardiac risk stratification in noncardiac surgery.
  • Its performance across diverse age groups in unselected populations requires systematic investigation.

Purpose of the Study:

  • To assess the relationship between RCRI and major adverse cardiovascular events (MACE).
  • To evaluate RCRI performance in an unselected cohort undergoing elective noncardiac surgery, stratified by age groups.

Main Methods:

  • A nationwide cohort study in Denmark (2005-2011) included patients aged ≥25 undergoing major elective noncardiac surgery.
  • Follow-up for 30-day MACE (ischemic stroke, myocardial infarction, cardiovascular death).
  • Multivariable logistic regression and C-statistic analysis were used to assess RCRI performance across age groups.

Main Results:

  • MACE rates increased with RCRI classes (0.2% in Class I to 8% in Class IV).
  • Key predictors of MACE included cerebrovascular disease (OR 10.02), ischemic heart disease (OR 3.30), and high-risk surgery (OR 2.70).
  • RCRI C-statistic was highest in the 56-65 age group (0.772) and lowest in those >85 years (0.683). Sensitivity for RCRI >I was moderate (59-71%), but negative predictive value exceeded 98% across all ages.

Conclusions:

  • RCRI performance in an unselected, nationwide cohort was comparable to the original study.
  • Identifying patients with ≥1 RCRI risk factor offers moderate sensitivity but high negative predictive value for MACE across all adult age groups.
Abstract